Nikko Asset Management Americas’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,490,600
| Closed | -$17.5M | – | 197 |
|
|
2023
Q2 | $17.5M | Sell |
2,490,600
-58,391
| -2% | -$410K | 0.18% | 74 |
|
|
2023
Q1 | $15.4M | Sell |
2,548,991
-38,627
| -1% | -$234K | 0.18% | 66 |
|
|
2022
Q4 | $16.5M | Sell |
2,587,618
-111,795
| -4% | -$713K | 0.24% | 64 |
|
|
2022
Q3 | $25.2M | Sell |
2,699,413
-100,229
| -4% | -$937K | 0.32% | 56 |
|
|
2022
Q2 | $29.7M | Buy |
2,799,642
+421,306
| +18% | +$4.47M | 0.37% | 58 |
|
|
2022
Q1 | $39.2M | Sell |
2,378,336
-2,586,760
| -52% | -$42.7M | 0.29% | 64 |
|
|
2021
Q4 | $82.6M | Sell |
4,965,096
-1,415,707
| -22% | -$23.6M | 0.43% | 45 |
|
|
2021
Q3 | $145M | Sell |
6,380,803
-1,343,985
| -17% | -$30.5M | 0.62% | 40 |
|
|
2021
Q2 | $199M | Buy |
7,724,788
+2,378,927
| +45% | +$61.1M | 0.78% | 39 |
|
|
2021
Q1 | $169M | Buy |
5,345,861
+921,951
| +21% | +$29.2M | 0.83% | 40 |
|
|
2020
Q4 | $205M | Buy |
4,423,910
+904,165
| +26% | +$42M | 1.17% | 31 |
|
|
2020
Q3 | $116M | Buy |
3,519,745
+765,177
| +28% | +$25.3M | 1.03% | 35 |
|
|
2020
Q2 | $75.4M | Buy |
2,754,568
+1,634,046
| +146% | +$44.7M | 0.99% | 32 |
|
|
2020
Q1 | $33.5M | Sell |
1,120,522
-205,987
| -16% | -$6.17M | 0.62% | 42 |
|
|
2019
Q4 | $36.7M | Sell |
1,326,509
-29,793
| -2% | -$825K | 0.58% | 48 |
|
|
2019
Q3 | $24.7M | Buy |
1,356,302
+92,206
| +7% | +$1.68M | 0.44% | 57 |
|
|
2019
Q2 | $31M | Buy |
1,264,096
+801,026
| +173% | +$19.6M | 0.61% | 45 |
|
|
2019
Q1 | $4.4M | Buy |
+463,070
| New | +$4.4M | 0.12% | 116 |
|